HI homepage

Joshua J. Cooper ACR American College of Radiology
American College of Radiology appoints new head of advocacy

Joshua J. Cooper brings 30 years of experience as the new ACR executive VP of government relations, economics and health policy.  

Chest radiograph in a 53-year-old woman with confirmed coronavirus disease 2019, or COVID-19, pneumonia. The patient had fever and cough for 5 days. Multifocal patchy opacities (arrows) can be seen in both lungs. Image courtesy of RSNA. What COVID looks like ob CT medical imaging.
Current imaging AI systems can be repurposed to address future pandemics, study asserts

Experts say these new findings represent “a significant advancement in the field of radiology."

Prominent organizations endorse new contrast-enhanced ultrasound curriculum and training

The endorsement follows recent program updates, implemented following an expansion to the Scope of Practice and Clinical Standards for the Diagnostic Medical Sonographer.

money maze benjamin franklin reimbursement medicare
UnitedHealthcare adds new roadblock around radiology reimbursement

An impending policy change from UHC could cause providers to jump through additional hoops to receive payment for some imaging-related services. 

Envision Radiology
Envision Radiology acquires private equity-backed imaging center operator Rezolut

With the deal, Envision will add a total of 42 freestanding centers across six states, ballooning its location count to more than 100 nationwide. 

REVENUE MONEY INCREASE DOLLAR GRAPH FINANCE
RadNet adds $100M in annual revenue, acquiring 13 imaging centers from LucidHealth

The company is expanding into southwest Florida, one of the Sunshine State’s fastest growing geographies, with the purchase of Radiology Regional. 

Around the web

RadNet Chaiman and CEO Howard Berger, MD, explains why the company has invested tens of millions into DeepHealth to rapidly build up a new business model. 

 

Thanks to AI, clinicians can use mammograms to do a lot more than identify signs of breast cancer. Researchers explored data from nearly 50,000 patients, presenting their findings in Heart.

A new analysis is prompting questions regarding how rigorously many of the AI-enabled tools approved by the U.S. Food and Drug Administration are evaluated prior to their clearance.